MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

21 May 2024 Evaluate
A decent increase of about 31.08% in the sales to Rs. 956.09 millions was observed for the quarter ended March 2024. The sales figure stood at Rs. 729.42 millions during the year-ago period.The company has announced a 27.21% increase in its profits to Rs . 108.50  millions for the  quarter ended March 2024 compared to Rs. 85.29 millions in the corresponding quarter in the previous year.The company reported a good operating profit of 167.60 millions compared to 133.21 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 956.09 729.42 31.08 3289.73 2750.52 19.60 3289.73 2750.52 19.60
Other Income 41.64 26.86 55.03 159.01 76.12 108.89 159.01 76.12 108.89
PBIDT 167.60 133.21 25.82 601.94 356.96 68.63 601.94 356.96 68.63
Interest 4.58 3.22 42.24 13.38 11.97 11.78 13.38 11.97 11.78
PBDT 163.02 129.99 25.41 588.56 344.99 70.60 588.56 344.99 70.60
Depreciation 20.64 19.17 7.67 81.48 78.99 3.15 81.48 78.99 3.15
PBT 142.38 110.82 28.48 507.08 266.00 90.63 507.08 266.00 90.63
TAX 33.88 25.53 32.71 121.89 64.81 88.07 121.89 64.81 88.07
Deferred Tax 1.13 -3.97 -128.46 7.76 -7.30 -206.30 7.76 -7.30 -206.30
PAT 108.50 85.29 27.21 385.19 201.19 91.46 385.19 201.19 91.46
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 17.53 18.26 -4.01 18.30 12.98 40.99 18.30 12.98 40.99
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..